Acute and Chronic Effects of Desipramine and Clorgyline on Alpha(2)-adrenoceptors Regulating Noradrenergic Transmission in the Rat Brain: a Dual-probe Microdialysis Study
Overview
Affiliations
1. The effects of desipramine (3 mg kg(-1) i.p.) and clorgyline (1 mg kg(-1) i.p.) on extracellular noradrenaline (NA) in the locus coeruleus (LC) and cingulate cortex were assessed in freely-moving rats by dual-probe microdialysis. Functional activities of alpha(2)-adrenoceptors regulating NA release in the LC and cingulate cortex were determined by systemic (0.3 mg kg(-1) i.p.) or local (0.1 - 100 microM) clonidine administration. 2. Extracellular NA was increased in the LC and cingulate cortex following acute desipramine but not clorgyline treatment. Systemic clonidine decreased NA similarly in desipramine-, clorgyline-, and saline-treated animals, in both brain areas. 3. Long-term (twice daily, 14 days) but not short-term (twice daily, 7 days) desipramine, and long-term clorgyline (once daily, 21 days) treatments increased NA (3 fold) in cingulate cortex but not in the LC. Following long-term treatments, responses of NA to systemic clonidine were attenuated in the LC and cingulate cortex. 4. Clonidine perfusion by reverse dialysis into the cingulate cortex decreased local NA (-55 +/- 9%). The effect was attenuated by long-term desipramine (-31 +/- 9%) and clorgyline (-10 +/- 2%) treatments. 5. Clonidine perfusion by reverse dialysis into the LC decreased NA in the LC (-89 +/- 2%) and in cingulate cortex (-52 +/- 12%). This effect was attenuated in the LC following long-term desipramine (-72 +/- 4%) and clorgyline (-62 +/- 12%) treatments but it was not modified in the cingulate cortex (-57 +/- 10% and -68 +/- 6%, respectively). 6. These findings demonstrate that chronic desipramine or clorgyline treatments increase NA in noradrenergic terminal areas and desensitize alpha(2)-adrenoceptors modulating local NA release at somatodendritic and terminal levels. However, somatodendritic alpha(2)-adrenoceptors that control LC firing activity are not desensitized.
Kaminska K, Lenda T, Konieczny J, Lorenc-Koci E Psychopharmacology (Berl). 2022; 239(11):3633-3656.
PMID: 36178508 PMC: 9584871. DOI: 10.1007/s00213-022-06238-x.
The role of adrenergic and muscarinic receptors in stress-induced cardiac injury.
Kurbatov B, Prokudina E, Maslov L, Naryzhnaya N, Logvinov S, Gorbunov A Pflugers Arch. 2021; 473(10):1641-1655.
PMID: 34245378 DOI: 10.1007/s00424-021-02602-6.
Murillo M, Aronsson P, Winder M, Carlsson T Heliyon. 2020; 6(11):e05472.
PMID: 33251357 PMC: 7679251. DOI: 10.1016/j.heliyon.2020.e05472.
Strategies to Treat Chronic Pain and Strengthen Impaired Descending Noradrenergic Inhibitory System.
Hayashida K, Obata H Int J Mol Sci. 2019; 20(4).
PMID: 30769838 PMC: 6412536. DOI: 10.3390/ijms20040822.
Fullana M, Ferres-Coy A, Ortega J, Ruiz-Bronchal E, Paz V, Meana J Mol Neurobiol. 2018; 56(4):3038-3052.
PMID: 30088175 DOI: 10.1007/s12035-018-1288-1.